Ad
related to: biogen'sreviewscout.org has been visited by 100K+ users in the past month
Search results
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Benzinga via Yahoo Finance· 11 hours agoOn Thursday, the European Commission granted marketing authorization under exceptional circumstances...
European Commission approves Biogen’s QALSODY for ALS treatment
Pharmaceutical Technology via Yahoo Finance· 19 hours agoThe European Commission (EC) has granted marketing authorisation for Biogen's QALSODY (tofersen) an...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Finance· 13 hours agoBiogen’s stock was up 2.6% on Thursday in response to Qalsody’s approval in the EU. Biogen’s stock...
European Commission grants marketing approval to Biogen's ALS drug
Reuters via Yahoo News· 1 day agoThe approval is based on a 108-patient trial that showed Qalsody reduced levels of a neurofilament...
Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors
Guru Focus· 12 hours agoLong-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth, and valuation ...
BIIB Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Biogen...
Benzinga· 3 hours agoRobbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. BIIB securities between February 3, 2022 ...
South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe South Korean Ministry of Food and Drug Safety (MFDS) has granted approval for Eisai and Biogen’s...
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Simply Wall St. via Yahoo Finance· 4 days agoIt is hard to get excited after looking at Biogen's (NASDAQ:BIIB) recent performance, when its stock...
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of...
Morningstar· 1 day agoThe Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. (“Biogen” or the “Company ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen...
Morningstar· 1 day agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain officers. The class action, filed in the United ...